NBIX: Neurocrine Price Target Chart

Neurocrine Biosciences (NBIX) is developing a partnership strategy by licensing promising molecules from small biotechs while maintaining the autonomy of its core R&D. The company creates advanced therapies for severe brain pathologies at the intersection of neurophysiology and biology. This price trend chart reflects the asset's dynamics, where the consensus forecast stands at 208.82. Stable income is ensured by patented drugs with lifelong consumption cycles and high margins.

Neurocrine (NBIX): Consensus Target from 07/04/2022 to 11/15/2026

Analytical breakdowns for Neurocrine (NBIX)

- stock price and consensus target price:

Share Price Neurocrine Biosciences, Inc.|NBIX - Analyst Consensus Forecast

- market capitalization information:

Market Value Neurocrine Corp|NBIX - Enterprise Value

- issuer book value statistics:

Net Assets per Share Neurocrine Biosciences|NBIX - Company Net Assets|Capitalization to Book Value Ratio neurocrine.com|NBIX - Aggregate Company Assets

- debt obligations and liquidity statistics:

Debt to Equity Ratio Neurocrine Biosciences|NBIX - Long-Term Debt to Capital|Current Liabilities to Capital Neurocrine Biosciences, Inc.|NBIX - Company Total Debt|Debts to Book Capitalization Neurocrine Biosciences|NBIX - Company Long-Term Debt|Company Short-Term Loans and Borrowings Neurocrine Biosciences|Immediate Liquidity neurocrine.com

- net income and valuation ratios data:

NBIX - Company Net Income|Net Profit Forecast Neurocrine Biosciences|NBIX - P/E Multiple|Projected Price to Earnings Ratio Neurocrine Biosciences|NBIX - Price/Earnings to Growth Multiple|EV/EBITDA Multiple Neurocrine Biosciences|NBIX - Profit before payment of interest, taxes and amortization|Earnings per share for the trailing year Neurocrine Biosciences|NBIX - Earnings per share for the last twelve months|Earnings per share growth in annualized terms for the last twelve months neurocrine.com|NBIX - Earnings growth in current year|Expected earnings per share growth for next year Neurocrine Biosciences

- sales revenue and business income indicators:

NBIX - Company Revenue|Company Future Revenue Neurocrine Biosciences, Inc.|NBIX - P/S Multiple|Market Cap to Expected Sales Ratio Neurocrine Biosciences

Summary company analytics:NBIX Neurocrine

Manufactured products of Neurocrine Biosciences, Inc.

Neurocrine Biosciences (NBIX) investments in cutting-edge neurobiological research and the fight against brain pathologies create high uncertainty regarding the value of future assets. This consolidated share price benchmark aggregates average expert target valuations, allowing investors to compare the current price with US industry medians to identify whether the business is overbought or undervalued in its current phase of development.

Competitors of Neurocrine Biosciences